Agomelatine in depression

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.12, Iss.6, 2013-11, pp. : 873-880

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Agomelatine has uplifting advantages in depression

Inpharma, Vol. 1, Iss. 1514, 2005-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Agomelatine for Bipolar Depression: A Chronotherapeutic Agent?

Current Psychopharmacology, Vol. 4, Iss. 2, 2016-02 ,pp. : 84-95

Bentham Science Publishers

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression

By Howland Robert H.

Drug Safety, Vol. 34, Iss. 9, 2011-09 ,pp. : 709-731

Adis International

Access to resources Recommend Favorite

A review of the efficacy and tolerability of agomelatine in the treatment of major depression

By Ghosh Anita Hellewell Jonathan SE

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1999-2004

Informa Healthcare

Access to resources Recommend Favorite

Melatonin Receptor Agonist Agomelatine: A New Drug for Treating Unipolar Depression

Current Pharmaceutical Design, Vol. 15, Iss. 14, 2009-05 ,pp. : 1675-1682

Bentham Science Publishers

Access to resources Recommend Favorite